Owens & Minor - OMI STOCK NEWS

Owens & Minor (NYSE: OMI) has announced a definitive agreement to acquire Rotech Healthcare Holdings for $1.36 billion in cash. The net purchase price is approximately $1.32 billion after anticipated tax benefits. Rotech, a national leader in home medical equipment, generated about $750 million in revenue with an EBITDA margin of nearly 30% in 2023. This acquisition aligns with Owens & Minor's strategy to expand in the home-based care space, strengthening its Patient Direct segment. The transaction is expected to be adjusted EPS neutral in the first full year and accretive by about $0.15 in the second year. Owens & Minor anticipates achieving synergies of approximately $50 million by the end of year three. The deal is subject to customary closing conditions and is expected to close by the end of 2024.

Owens & Minor (NYSE: OMI), a global healthcare solutions company, will participate in the Leerink Partners’ Healthcare Crossroads Conference on May 29, 2024. CEO Ed Pesicka and CFO Alex Bruni will host a webcasted fireside chat at 11:00 a.m. EDT. The company will also conduct one-on-one meetings with investors. Owens & Minor specializes in providing healthcare products, self-manufactured items, proprietary product portfolios, distribution services, and innovative technology. With over 20,000 employees, the company aims to support healthcare from the hospital to the home. For more information, visit their investor relations page or their website.

Owens & Minor, Inc. (NYSE: OMI) will be participating in the BofA Securities 2024 Health Care Conference on May 15, 2024. The company will have a webcasted fireside chat and one-on-one meetings with investors. Owens & Minor is a Fortune 500 global healthcare solutions company providing essential products and services. For more information, visit their website or follow them on social media.

Owens & Minor, Inc. (NYSE: OMI) reported financial results for Q1 2024 with consolidated revenue of $2.6 billion, a 4% YoY growth. GAAP EPS loss of $(0.29) and adjusted EPS of $0.19. Investments for long-term growth are on track. The company delivered top-line growth, improved profitability, and made strategic investments. The outlook for 2024 includes revenue of $10.5B to $10.9B, adjusted EBITDA of $550M to $590M, and adjusted EPS of $1.40 to $1.70.

Owens & Minor, Inc. (NYSE: OMI) will release its financial results for the first quarter of 2024 on May 3, 2024, before trading begins on the NYSE. A conference call for investors and analysts will be held at 8:30 a.m. ET on the same day. Participants can access the call via toll-free or toll dial-in numbers. Interested stakeholders are encouraged to join the live webcast on the company's investor relations page.

Owens & Minor, Inc. (OMI) reported strong financial results for the fourth quarter and full year 2023 with consolidated revenue of $10.3 billion, $741 million of operating cash flow, and significant debt reduction. The company showcased top-line growth, robust profit growth, and exceptional operating cash flow. The financial summary highlighted revenue, operating income, net income, and adjusted EBITDA for both periods. The fourth quarter results included consolidated revenue of $2.7 billion, operating income of $60 million, and adjusted operating income of $111 million. The company provided a financial outlook for 2024 with revenue expected to be in the range of $10.5 billion to $10.9 billion, adjusted EBITDA in the range of $550 million to $590 million, and adjusted EPS in the range of $1.40 to $1.70.

Owens & Minor, Inc. (OMI) will release its Q4 2023 financial results on February 20, 2024, before trading begins on NYSE. An investor and analyst conference call will be held at 8:30 a.m. ET on the same day. Stakeholders can access the call via toll-free or toll dial-in numbers, along with a simultaneous live webcast. A replay of the webcast will be available on the investor relations page of the company's website.

Owens & Minor, Inc. (NYSE: OMI) has unveiled its new purpose, Life Takes Care, reflecting the company's unique approach to caring for both the business and the humanity at the heart of healthcare. The President & Chief Executive Officer, Edward A. Pesicka, emphasizes the importance of defining this sense of purpose to better harness the collective strength, creativity, and compassion of the company's teammates as they continue to move the business forward.

Owens & Minor, Inc. (NYSE: OMI) unveils a new five-year strategic plan targeting 20% compounded earnings growth between 2024 to 2028. The plan aims to unlock expanded profitability and growth profiles through investments, strong cash generation, and a value-enhancing capital allocation program.